Drugs / Bifidobacterium longum R0175

Trials 3

20142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 01 trial
Phase 0 NCT04065503 Dec 2019 → Feb 2020 — University of Florida Completed No outcome recorded
Phase 21 trial · 1 missed
Phase 2 NCT02124759 Apr 2014 → Feb 2018 — The University of Texas Health Science Center at San Antonio Completed Missed primary
Phase not applicable1 trial
— NCT03877393 Apr 2019 → Jul 2020 major depressive disorder Medical University of Lublin Unknown No outcome recorded
Comparator or background therapy1 trial
Phase 2 NCT02127125 Comparator Apr 2014 → Sep 2018 — The University of Texas Health Science Center at San Antonio Completed No outcome recorded

Evidence & citations 4 cited values

Every value below carries the sentence it was read from. 4 sources stand behind the page.

FieldValueCited text
Known as Bifidobacterium longum R0175 “5 g of oligofructose + 1 g Bifidobacterium longum R0175 (4 billion colony forming units (CFU)/g) three times a day.” NCT02124759 ↗
1

“5 g of oligofructose + 1 g Bifidobacterium longum R0175” NCT02127125 ↗

Known as B. Longum R-0175 “A commercial product containing L. helveticus R0052, L. casei HA-108, B. breve HA-129, and B. longum R0175 and S. thermophilus HA-110 be given to healthy adults across a...” NCT04065503 ↗
1

“Detection and Persistence of a Product Containing L. Helveticus R-0052, L. Casei HA-108, B. Breve HA-129, B. Longum R-0175 and S. Thermophilus HA-110 in Healthy Adults: an...” NCT04065503 ↗

Known as Bifidobacterium longumRosell-175 “one capsule containing the probiotic mixture powder (Sanprobi Stress; Sanprobi sp. z o.o., sp.k., Szczecin, Poland) in the amount of 3 × 10\^9 colony forming units (CFU) per...” NCT03877393 ↗
Route Oral “The participants will be asked to consume supplements before breakfast.” NCT03877393 ↗